![Anant Bhan on Twitter: "This is still a live ad for the Gandhi Medical College as a trial site on the college website https://t.co/TEkLxRygUx https://t.co/Dkl4zX9ZH8" / Twitter Anant Bhan on Twitter: "This is still a live ad for the Gandhi Medical College as a trial site on the college website https://t.co/TEkLxRygUx https://t.co/Dkl4zX9ZH8" / Twitter](https://pbs.twimg.com/media/EravGHOVkAAcXmQ.png)
Anant Bhan on Twitter: "This is still a live ad for the Gandhi Medical College as a trial site on the college website https://t.co/TEkLxRygUx https://t.co/Dkl4zX9ZH8" / Twitter
![clinical trial | animals studies | phases of clinical trial are explained in telugu by doctor genius - YouTube clinical trial | animals studies | phases of clinical trial are explained in telugu by doctor genius - YouTube](https://i.ytimg.com/vi/ziVLjTFb1yo/maxresdefault.jpg)
clinical trial | animals studies | phases of clinical trial are explained in telugu by doctor genius - YouTube
![Bharat Biotech's nasal vaccine can be a gamechanger in fight against Covid: All you need to know | India News – India TV Bharat Biotech's nasal vaccine can be a gamechanger in fight against Covid: All you need to know | India News – India TV](https://resize.indiatvnews.com/en/resize/newbucket/715_-/2021/04/nasalvaccine-1619440113.jpg)
Bharat Biotech's nasal vaccine can be a gamechanger in fight against Covid: All you need to know | India News – India TV
![Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial - The Lancet Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8b72eb65-35f0-4367-abe2-49882d563804/gr1_lrg.gif)